• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular implications of anti-angiogenic therapeutic agents in cancer patients.

作者信息

Al Mahmasani Layal, Abou-Alfa Ghassan K

机构信息

Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, USA.

Weill Medical College, Cornell University, New York, NY, USA.

出版信息

Am Heart J Plus. 2024 May 23;43:100406. doi: 10.1016/j.ahjo.2024.100406. eCollection 2024 Jul.

DOI:10.1016/j.ahjo.2024.100406
PMID:39006541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245762/
Abstract
摘要

相似文献

1
Cardiovascular implications of anti-angiogenic therapeutic agents in cancer patients.抗血管生成治疗药物对癌症患者心血管系统的影响
Am Heart J Plus. 2024 May 23;43:100406. doi: 10.1016/j.ahjo.2024.100406. eCollection 2024 Jul.
2
Antineovascular therapy, a novel antiangiogenic approach.抗血管生成疗法，一种新型的抗血管生成方法。
Expert Opin Ther Targets. 2005 Feb;9(1):63-76. doi: 10.1517/14728222.9.1.63.
3
Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity.肿瘤抑制因子maspin在角质形成细胞衰老过程中上调，发挥旁分泌抗血管生成活性。
Cancer Res. 2004 May 1;64(9):2956-61. doi: 10.1158/0008-5472.can-03-2388.
4
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy.上皮性卵巢癌的抗血管生成策略：机制、耐药性及联合治疗
J Oncol. 2022 Apr 12;2022:4880355. doi: 10.1155/2022/4880355. eCollection 2022.
5
Heme Oxygenase-1, Cardiac Senescence, and Myocardial Infarction: A Critical Review of the Triptych.血红素加氧酶-1、心脏衰老与心肌梗死：对三联症的批判性综述
Cardiovasc Drugs Ther. 2024 Jun 28. doi: 10.1007/s10557-024-07590-0.
6
[Arterial hypertension in cancer patients treated with antiangiogenic agents].[接受抗血管生成药物治疗的癌症患者的动脉高血压]
Hipertens Riesgo Vasc. 2021 Jul-Sep;38(3):151-155. doi: 10.1016/j.hipert.2021.02.003. Epub 2021 Mar 9.
7
Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.晚年前列腺血管生成反应：抗血管生成疗法对小鼠前列腺转基因腺癌（TRAMP）模型中腺微环境的影响及其关系。
Prostate. 2015 Apr 1;75(5):484-99. doi: 10.1002/pros.22934. Epub 2014 Dec 17.
8
Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process.利用纳米颗粒干扰血管供应和血管生成过程治疗难治性疾病。
Eur J Med Res. 2022 Nov 4;27(1):232. doi: 10.1186/s40001-022-00833-6.
9
Cellular Senescence in Cardiovascular Diseases: A Systematic Review.心血管疾病中的细胞衰老：一项系统综述
Aging Dis. 2022 Feb 1;13(1):103-128. doi: 10.14336/AD.2021.0927. eCollection 2022 Feb.
10
Anti-angiogenesis in cancer therapeutics: the magic bullet.癌症治疗中的抗血管生成：灵丹妙药。
J Egypt Natl Canc Inst. 2021 Jul 2;33(1):15. doi: 10.1186/s43046-021-00072-6.

本文引用的文献

1
Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA).癌症靶向治疗和免疫治疗心血管毒性的新见解：超越非阻塞性冠状动脉缺血（INOCA）。
Am Heart J Plus. 2024 Mar 1;40:100374. doi: 10.1016/j.ahjo.2024.100374. eCollection 2024 Apr.
2
Screening for Coronary Artery Disease in Cancer Survivors: State-of-the-Art Review.癌症幸存者冠状动脉疾病的筛查：最新综述
JACC CardioOncol. 2023 Feb 21;5(1):22-38. doi: 10.1016/j.jaccao.2022.12.007. eCollection 2023 Feb.
3
Cardiovascular Toxicity Induced by Vascular Endothelial Growth Factor Inhibitors.血管内皮生长因子抑制剂所致的心血管毒性
Life (Basel). 2023 Jan 29;13(2):366. doi: 10.3390/life13020366.
4
Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics.血管疾病中的血管内皮衰老：衰老治疗学的现有认识和未来机遇。
Exp Mol Med. 2023 Jan;55(1):1-12. doi: 10.1038/s12276-022-00906-w. Epub 2023 Jan 4.
5
Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers.胃肠道和肝胆癌中当前及新兴的抗血管生成疗法
Front Oncol. 2022 Oct 10;12:1021772. doi: 10.3389/fonc.2022.1021772. eCollection 2022.
6
Cellular senescence: the good, the bad and the unknown.细胞衰老：好的、坏的和未知的。
Nat Rev Nephrol. 2022 Oct;18(10):611-627. doi: 10.1038/s41581-022-00601-z. Epub 2022 Aug 3.
7
Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer.心脏肿瘤学：心血管疾病与癌症之间的众多关联
Front Cardiovasc Med. 2022 Mar 17;9:727487. doi: 10.3389/fcvm.2022.727487. eCollection 2022.
8
Endothelial dysfunction as a complication of anti-cancer therapy.癌症治疗的并发症：内皮功能障碍。
Pharmacol Ther. 2022 Sep;237:108116. doi: 10.1016/j.pharmthera.2022.108116. Epub 2022 Jan 19.
9
Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors.癌症幸存者治疗诱导的内皮细胞衰老的心血管后果。
Biochim Biophys Acta Mol Basis Dis. 2022 Apr 1;1868(4):166352. doi: 10.1016/j.bbadis.2022.166352. Epub 2022 Jan 15.
10
An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging.基于深度学习的炎症性衰老时钟 (iAge) 可追踪多种疾病、免疫衰老、虚弱和心血管衰老。
Nat Aging. 2021 Jul;1:598-615. doi: 10.1038/s43587-021-00082-y. Epub 2021 Jul 12.